Pilot Study of Percutaneous Correction of Hallux Valgus
ConditionHallux Valgus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorIstituto Ortopedico Rizzoli
This is a pilot study with a randomized controlled design.
Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
HVA (hallux valgus angle): 20°-40°
IMA (intermetatarsal angle): 10°-20°
Patients with instability of the first metatarsophalangeal joint
Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
patients requiring additional surgical procedures
patients with severe vascular and neurological systemic pathologies